Search

Your search keyword '"Vaia, Francesco"' showing total 291 results

Search Constraints

Start Over You searched for: Author "Vaia, Francesco" Remove constraint Author: "Vaia, Francesco"
291 results on '"Vaia, Francesco"'

Search Results

2. Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study

3. Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications

4. Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study)

6. Kinetics of viral DNA in body fluids and antibody response in patients with acute Monkeypox virus infection

7. Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)

8. Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study

9. SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis

12. A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19

13. Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results

14. Epidemiology of ventilator-associated pneumonia in ICU COVID-19 patients: an alarming high rate of multidrug-resistant bacteria

15. Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV

16. Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine

17. Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injection

19. Predictors of Mortality and Orotracheal Intubation in Patients with Pulmonary Barotrauma Due to COVID-19: An Italian Multicenter Observational Study during Two Years of the Pandemic

21. Nutrition, Physical Activity and Smoking Habit in the Italian General Adult Population: CUORE Project Health Examination Survey 2018–2019

22. Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia

23. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital

24. The role of pharmacies in the implementation of vaccination coverage in Italy. Insights from the preliminary data of the Lombardy Region.

25. 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation

26. Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies

27. Pharmacokinetic of Tecovirimat in subjects with Mpox

28. Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study)

29. Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis

30. Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV

31. In Vitro and In Vivo Crosstalk between Type I IFN and IL-8 Responses in SARS-CoV-2 Infection

32. Torquetenovirus Loads in Peripheral Blood Predict Both the Humoral and Cell-Mediated Responses to SARS-CoV-2 Elicited by the mRNA Vaccine in Liver Transplant Recipients

33. Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients

34. Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in PLWH

35. Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination

36. Kinetics of TTV Loads in Peripheral Blood Mononuclear Cells of Early Treated Acute HIV Infections

37. Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications

38. Neutralizing activity and T-cell response after bivalent fifth dose of messenger RNA vaccine in people living with HIV

39. A Case of Severe Mpox Complicated with Streptococcus pyogenes Sepsis in a Patient with HIV Infection

40. Pharmacokinetics of tecovirimat in subjects with Mpox

42. Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox

43. Evolution of SARS‐CoV‐2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID‐19 in an Italian reference hospital: Impact on clinical outcomes

44. Temporal intra‐host variability of mpox virus genomes in multiple body tissues

45. The possible effect of sociobehavioral factors and public health actions on the mpox epidemic slowdown

47. Pharyngo-tonsillar involvement of Mpox in a cohort of men who have sex with men (MSM): A serious risk of missing diagnosis

48. Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant

49. Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)

50. Characterization of the immune impairment of tuberculosis and COVID-19 coinfected patients

Catalog

Books, media, physical & digital resources